fundvisualizer.com

Ashmore Emerging Mkts Corp Inc CECDCX

Performance (before sales charge)

As of 02/28/2023

All information is historical and not indicative of future results. Current performance may be lower or higher than the quoted past performance, which cannot guarantee results. Share price, principal value, and return will vary, and you may have a gain or a loss when you sell your shares. Performance assumes reinvestment of distributions and does not account for taxes. After-sales-charge returns reflect the maximum sales charge applicable to the fund. Performance may not reflect any expense limitation or subsidies currently in effect. Short-term trading fees may apply. To obtain the most recent month-end performance, visit Morningstar.com.

Asset allocation

As of 12/31/2022
Stock
0.00%
Non-U.S. Stock
0.83%
Bond
1.42%
Non-U.S. Bond
89.60%
Preferred
0.00%
Convertible
1.03%
Cash
7.12%
Other
0.00%

Due to rounding, percentages may not equal 100%.

Sectors

As of 12/31/2022

Basic materials

0.00%

Consumer cyclical

0.00%

Financial services

0.00%

Real estate

0.00%

Consumer defensive

0.00%

Health care

0.00%

Utilities

0.00%

Communication services

0.00%

Energy

0.83%

Industrials

0.00%

Technology

0.00%

Top 10 holdings

As of 12/31/2022

Cash
2.06%
Puma International Financing S.A. 5%
1.80%
Teva Pharmaceutical Finance Netherlands III B.V. 6.75%
1.69%
Petroleos de Venezuela SA 8.5%
1.54%
YPF Sociedad Anonima 4%
1.49%
International Airport Finance SA 12%
1.41%
InterCement Financial Operations B.V. 5.75%
1.31%
DNO ASA 7.875%
1.25%
Teva Pharmaceutical Finance Company LLC 6.15%
1.17%
C&W Senior Financing Designated Activity Company 6.875%
1.07%
Fund assets

$91 Million

Share class

C

Morningstar category

Emerging Markets Bond

Expense ratio

1.87%

Investment objective

Income

Documents